INM Stock Analysis: Buy, Sell, or Hold?
INM - InMed Pharmaceuticals Inc. Common Shares
$1.50
0.00 (0.00%)
▲
5d:
-0.66%
30d:
-13.29%
90d:
+97.11%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Get Alerted When INM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: INM shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: INM shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: INM is currently trading at $1.50, which is considered fair relative to its 30-day fair value range of $1.35 to $1.73.
Technical Outlook: Technically, INM is in a uptrend. The price is currently testing key support at $1.48. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $20.00 (+1233.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INM is in a uptrend. The price is currently testing key support at $1.48. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $20.00 (+1233.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.35 -
$1.73
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1233.3% below Wall St target ($20.00)
Trading Range Analysis
30-Day Trading Range
$1.35 -
$1.73
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.48
Resistance Level
$1.75
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$20.00
(+1233.3%)
Revenue Growth (YoY)
-26.2%
Profit Margin
-172.2%
Share & Embed Analysis
Last updated: June 24, 2026 4:21 AM ET
Data refreshes hourly during market hours. Next update: 5:21 AM
Data refreshes hourly during market hours. Next update: 5:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 60 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 64 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 67 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 58 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 57 HOLD |
